Literature DB >> 33146814

Purinergic Signaling in the Central Nervous System in Health and Disease.

Peter Illes1,2, Guang-Yin Xu3, Yong Tang4,5.   

Abstract

Mesh:

Substances:

Year:  2020        PMID: 33146814      PMCID: PMC7674523          DOI: 10.1007/s12264-020-00602-7

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


× No keyword cloud information.
  35 in total

Review 1.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

Review 2.  Purinergic nerves.

Authors:  G Burnstock
Journal:  Pharmacol Rev       Date:  1972-09       Impact factor: 25.468

Review 3.  Purinergic Modulation of Activity in the Developing Auditory Pathway.

Authors:  Sasa Jovanovic; Ivan Milenkovic
Journal:  Neurosci Bull       Date:  2020-10-11       Impact factor: 5.203

Review 4.  Implication of Neuronal Versus Microglial P2X4 Receptors in Central Nervous System Disorders.

Authors:  Alexia Duveau; Eléonore Bertin; Eric Boué-Grabot
Journal:  Neurosci Bull       Date:  2020-09-05       Impact factor: 5.203

5.  The role of adenosine in the maturation of sleep homeostasis in rats.

Authors:  Irma Gvilia; Natalia Suntsova; Andrey Kostin; Anna Kalinchuk; Dennis McGinty; Radhika Basheer; Ronald Szymusiak
Journal:  J Neurophysiol       Date:  2016-10-26       Impact factor: 2.714

Review 6.  Purinergic neurone-glia signalling in cognitive-related pathologies.

Authors:  Peter Illes; Alexei Verkhratsky
Journal:  Neuropharmacology       Date:  2015-08-06       Impact factor: 5.250

7.  Microglia monitor and protect neuronal function through specialized somatic purinergic junctions.

Authors:  Csaba Cserép; Balázs Pósfai; Nikolett Lénárt; Rebeka Fekete; Zsófia I László; Zsolt Lele; Barbara Orsolits; Gábor Molnár; Steffanie Heindl; Anett D Schwarcz; Katinka Ujvári; Zsuzsanna Környei; Krisztina Tóth; Eszter Szabadits; Beáta Sperlágh; Mária Baranyi; László Csiba; Tibor Hortobágyi; Zsófia Maglóczky; Bernadett Martinecz; Gábor Szabó; Ferenc Erdélyi; Róbert Szipőcs; Michael M Tamkun; Benno Gesierich; Marco Duering; István Katona; Arthur Liesz; Gábor Tamás; Ádám Dénes
Journal:  Science       Date:  2019-12-12       Impact factor: 47.728

Review 8.  Purines: From Diagnostic Biomarkers to Therapeutic Agents in Brain Injury.

Authors:  Bruno G Frenguelli; Nicholas Dale
Journal:  Neurosci Bull       Date:  2020-06-15       Impact factor: 5.203

Review 9.  Regulation of Microglial Functions by Purinergic Mechanisms in the Healthy and Diseased CNS.

Authors:  Peter Illes; Patrizia Rubini; Henning Ulrich; Yafei Zhao; Yong Tang
Journal:  Cells       Date:  2020-04-29       Impact factor: 6.600

10.  Pathological ATPergic Signaling in Major Depression and Bipolar Disorder.

Authors:  Peter Illes; Alexei Verkhratsky; Yong Tang
Journal:  Front Mol Neurosci       Date:  2020-01-31       Impact factor: 5.639

View more
  3 in total

1.  P2Y12 receptor gene polymorphisms are associated with epilepsy.

Authors:  Qi Wang; Nan-Rui Shi; Peng Lv; Juan Liu; Ji-Zhou Zhang; Bin-Lu Deng; Yan-Qin Zuo; Jie Yang; Xin Wang; Xiang Chen; Xiu-Min Hu; Ting-Ting Liu; Jie Liu
Journal:  Purinergic Signal       Date:  2022-02-17       Impact factor: 3.765

Review 2.  MicroRNA: Crucial modulator in purinergic signalling involved diseases.

Authors:  Jing Guo; Peng Yang; Yi-Fan Li; Jin-Fan Tang; Zhao-Xuan He; Shu-Guang Yu; Hai-Yan Yin
Journal:  Purinergic Signal       Date:  2022-02-02       Impact factor: 3.765

Review 3.  Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor.

Authors:  Beatriz Gil; Jonathon Smith; Yong Tang; Peter Illes; Tobias Engel
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.